Syndax Pharmaceuticals Garners $4,947,480 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=256cec88-6fcc-4003-9b87-4ee6b3fe2e8e - Date
9/22/2014 - Company Name
Syndax Pharmaceuticals - Mailing Address
400 Totten Pond Road Waltham, MA 02451 USA - Company Description
Syndax Pharmaceuticals, Inc. is a Waltham, MA-based, oncology-focused biotechnology company that is building a portfolio of new oncology products to extend and improve the lives of patients by developing and commercializing novel cancer therapies in optimized, mechanistically driven combination regimens. - Website
http://www.syndax.com - Transaction Type
Debt - Transaction Amount
$4,947,480 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
